Senior Medical Researcher

Dr. Moshe Ehrenberg

Dr. Moshe Ehrenberg, MD, GCP, an expert in macular degeneration, serves as the Senior Medical Researcher at Healables, Ltd. and champions the Ci2i.tech product line.  He has seen over 25,000 ophthalmology patients over 47 years, participated in 32 International Conference Presentations and published 17 papers in Major Peer Reviewed Ophthalmology Journals.  Dr. Ehrenberg is an Emeritus Active Fellow of the Retina Society and a Fellow of the Johns Hopkins Medical and Surgical Association.

​

Previously, at the Retinal Angiogenesis Laboratories of the Hebrew University of Jerusalem, Dr. Ehrenberg investigated and published articles concerning future therapies for macular degeneration.

​

A graduate of Johns Hopkins Medical School, Dr. Ehrenberg began his dedication to ophthalmology, by performing uveitis research in sympathetic ophthalmia for one year under the auspices of Professor Arthur Silverstein at the Wilmer Institute.  At the University of Chicago-Billings Hospital, he completed his Ophthalmology Residency under the directorship of Professor Frank Newell, where he combined intensive clinical experience with further development of his medical writing expertise and clinical research in Macular Degeneration.

​

Subsequently, at the Duke University Eye Center under the training of Professor Robert Machemer, and under the sponsorships of Fight for Sight, The National Society to Prevent Blindness, The National Eye Institute, The Retina Research Foundation, and The Society of Heed Fellows, Dr. Ehrenberg  performed a combined clinical and research Retina Fellowship with publications in peer-reviewed ophthalmology journals concerning advances in macular degeneration, diabetic retinopathy and other sight-threatening retinal vascular disorders.

​

Later, Dr. Ehrenberg became the Director of Vitreo-Retinal Surgery at the University of Kansas Medical Center, followed by an appointment as the Medical Director of the National Society to Prevent Blindness. 

CBDO

Marco Van Der Putten Landau

Marco van der Putten Landau is an international business development professional with expertise in bringing medical devices to market in general and 6 years in ophthalmology in particular.  

He serves as CBDO at Healables Ltd. focusing on the Ci2i and ElectroGear Product lines.
Marco has worked and lived in Europe, South America, China and Israel and is fluent in English, French, Italian, Dutch, Portuguese, Spanish and Chinese. 

Previously with BELKIN Vision, a company developing an efficient, non-contact, and automated glaucoma laser therapy accessible for all ophthalmologists, his responsibilities included expansion across Asia and Latin America, mainly China, Mexico and Brazil.